The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial
An immunosuppressed state, such as in the presence of HIV infection, can complicate the workup of brain lesions, and so several paradigms for diagnosis and initial treatment are reviewed here.